Clinical trial
Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers
NCT05356936 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- August 1, 2024
- Enrollment
- 151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.